Marino Stram & Associates’s Dianthus Therapeutics DNTH Stock Holding History

Marino Stram & Associates’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-102	Closed	-$27K	–	202
2019 Q1	$27K	Hold	102	–	–	0.02%	213
2018 Q4	$9K	Hold	102	–	–	0.01%	285
2018 Q3	$20K	Buy	+102	New	+$21.5K	0.02%	245
2018 Q2	–	Hold	0	–	–	–	232

Other funds holding DNTH

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return